Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theravance Bio Ord 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 USA

www.theravance.com Employees: 97 P: 650-808-6000

Sector:

Medical

Description:

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'

Key Statistics

Overview:

Market Capitalization, $K 924,764
Enterprise Value, $K 886,964
Shares Outstanding, K 50,672
Float, K 47,176
% Float 93.10%
Short Interest, K 4,422
Short Float 8.73%
Days to Cover 13.37
Short Volume Ratio 0.74
% of Insider Shareholders 6.90%
% of Institutional Shareholders 99.10%

Financials:

Annual Sales, $ 64,380 K
Annual Net Income, $ -56,420 K
Last Quarter Sales, $ 19,990 K
Last Quarter Net Income, $ 3,620 K
EBIT, $ -32,820 K
EBITDA, $ -33,620 K

Growth:

1-Year Return 96.87%
3-Year Return 81.23%
5-Year Return -6.17%
5-Year Revenue Growth -12.30%
5-Year Earnings Growth 72.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 11/10/25
Next Earnings Date 02/25/26
Earnings Per Share ttm 0.47
EPS Growth vs. Prev Qtr -102.78%
EPS Growth vs. Prev Year 88.46%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TBPH Ratios

Ratio
Price/Earnings ttm 38.83
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 12.20%
Return-on-Assets % 6.33%
Profit Margin % -87.64%
Debt/Equity 0.00
Price/Sales 11.49
Price/Cash Flow N/A
Price/Book 3.95
Book Value/Share 4.62
Interest Coverage -16.49
60-Month Beta 0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar